Organ Dysfunction during Systemic Inflammation
Clinical Research Unit CRU342 – Bridging Basic Science and Clinical Research
Systemic Inflammation and Organ Dysfunction. Serious clinical problems
The Clinical Research Unit CRU342 will identify and investigate the different pathophysiological mechanisms that contribute to the development of this devastating diseases. We target possible interventional strategies in preclinical disease models and conduct clinical studies to enforce clinical translation of the results and to discover avenues of potential therapeutic approaches to combat organ injury during systemic inflammation.
27.01.26
21.01.26
21.01.26
Oguama M, Lindental P, Clemens RA, Lowell CA, Soehnlein O, Roth J, Bakchoul T, Cappenberg A, Zarbock A. Integrin activation by two independently regulated calcium-mediated pathways is required for neutrophil recruitment. Cell Commun Signal. 2026 Jan 21. doi: 10.1186/s12964-026-02666-w. Epub ahead of print. PMID: 41566499.
14.12.25
Schreiber A, Oberberg N, Ambrosy B, Rodner F, Kumar S, Caliskan DM, Brunotte L, Beer M, Ludwig S. Influenza H5Nx viruses are susceptible to MEK1/2 inhibition by zapnometinib. Emerg Microbes Infect. 2025 Dec;14(1):2471022. doi: 10.1080/22221751.2025.2471022. Epub 2025 Mar 17. PMID: 39976482; PMCID: PMC11915740.
28.10.25
14.10.25
24.09.25
22.09.25
18.09.25
14.09.25
15.08.25
12.06.25
Cappenberg A, Oguama M, Richter M, Margraf A, Amini W, Lindental P, Mersmann S, Bardel B, Block H, Vogl T, Soehnlein O, Ley K, Rossaint J, Zarbock A. RhoA GAP Myo9b regulates β2-integrin activity and neutrophil recruitment during murine acute kidney injury. Blood. 2025 Jun 12:blood.2024027583. doi: 10.1182/blood.2024027583. Epub ahead of print. PMID: 40504998.
10.06.25
Amini W, Schemmelmann L, Heming JN, Oguama M, Thomas K, Block H, Lindental P, Bardel B, Margraf A, Soehnlein O, Cappenberg A, Zarbock A. Csk-mediated Src family kinase regulation dampens neutrophil infiltration during pulmonary infection. JCI Insight. 2025 Jun 10:e188323. doi: 10.1172/jci.insight.188323. Epub ahead of print. PMID: 40493407.
24.05.25
Thomas K, Rossaint J, Ludwig N, Mersmann S, Kötting N, Grenzheuser J, Schemmelmann L, Oguama M, Margraf A, Block H, Henke K, Hellenthal K, Mirakaj V, Gerke V, Hansen U, Gäher K, Engelhardt M, Roth J, Eble J, Hub E, Rot A, Alon R, Zarbock A. Alveolar epithelial and vascular CXCR2 mediates transcytosis of CXCL1 in inflamed lungs. Nat Commun. 2025 May 24;16(1):4846. doi: 10.1038/s41467-025-60174-w. PMID: 40413164; PMCID: PMC12103508.
23.05.25
Hunkemöller A, Wirth T, Rovas A, Pavenstädt H, Klotz L, Kümpers P. Changes in immune cell signatures during early infection reflect decoupling of capillary perfusion and glycocalyx dimensions. Front Immunol. 2025 May 23;16:1589959. doi: 10.3389/fimmu.2025.1589959. PMID: 40486505; PMCID: PMC12140986.
15.05.25
Honig N, Teubert C, Lamparter L, Keller MN, Austermann J, Berger P, Schmitz A, Rasch C, Nüsse H, Klingauf J, Erpenbeck L, Roth J, Galic M. Primary human neutrophils and monocytes migrate along endothelial cell boundaries to optimize search efficiency under static in vitro conditions. Biol Open. 2025 May 15;14(5):bio061704. doi: 10.1242/bio.061704. Epub 2025 May 13. PMID: 40357751.
23.04.25
Sowa MA, Wu Y, van Groningen J, Di Y, van den Hurk H, Eble JA, Gibbins JM, García Á, Pollitt AY. High-throughput screen identifies MAS9 as a novel inhibitor of the C-type lectin receptor-2 (CLEC-2)-podoplanin interaction. Br J Pharmacol. 2025 Aug;182(16):3838-3851. doi: 10.1111/bph.70036. Epub 2025 Apr 23. PMID: 40269496.
29.11.24
Schughart K, Möller-Kerutt A, Höffken V, Nedvetsky P, Groh AC, Braun DA, Pavenstädt H, Weide T. PALS1-dependent modulations of mRNA profiles in MDCK II cells grown in non-confluent monolayers and three-dimensional cysts. BMC Genom Data. 2024 Nov 29;25(1):102. doi: 10.1186/s12863-024-01284-0. PMID: 39614182; PMCID: PMC11607895.
18.09.24
12.08.24
29.01.24
Meersch M, Weiss R, Strauß C, Albert F, Booke H, Forni L, Pittet JF, Kellum JA, Rosner M, Mehta R, Bellomo R, Rosenberger P, Zarbock A; EPIS-AKI Investigators. Acute kidney disease beyond day 7 after major surgery: a secondary analysis of the EPIS-AKI trial. Intensive Care Med. 2024 Feb;50(2):247-257. doi: 10.1007/s00134-023-07314-2. Epub 2024 Jan 29
28.07.23
Zarbock A, Weiss R, Albert F, Rutledge K, Kellum JA, Bellomo R, Grigoryev E, Candela-Toha AM, Demir ZA, Legros V, Rosenberger P, Galán Menéndez P, Garcia Alvarez M, Peng K, Léger M, Khalel W, Orhan-Sungur M, Meersch M; The EPIS-AKI Investigators. Epidemiology of surgery associated acute kidney injury (EPIS-AKI): a prospective international observational multi-center clinical study. Intensive Care Med. 2023 Jul 28. doi: 10.1007/s00134-023-07169-7. Epub ahead of print.